Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007644 · ClinicalTrials.gov registry record · Phase 3
Prostate Cancer Intervention Versus Observation Trial (PIVOT)
A Phase 3 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 3
- Development phase
- 731
- Enrollment target
NCT00007644: Completed Phase 3 study, sponsored by VA Office of Research and Development.
NCT00007644 is a Phase 3 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 731 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007644, a Phase 3 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 731 participants
- Enrollment target
Study Summary
Radical prostatectomy provides potentially curative removal of the cancer. However, it subjects patients to the morbidity and mortality of the surgery and may be neither necessary nor effective. Expectant management does not offer potential cure. However, it provides palliative therapy for symptomatic or metastatic disease progression, avoids potentially excessive and morbid interventions in asymptomatic patients, and emphasizes management approaches for focus on relieving symptoms while minimizing therapeutic complications. The primary objective of this study is to determine which of two strategies is superior for the management of clinically localized CAP: 1) radical prostatectomy with early aggressive intervention for disease persistence or recurrence, 2) expectant management with reservation of therapy for palliative treatment of symptomatic or metastatic disease progression. Outcomes include total mortality, CAP mortality, disease free and progression free survival, morbidity, quality of life, and cost effectiveness.
Interventions
- PROCEDURE Radical prostatectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 731 participants |
| Start Date | 1994-11 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00007644
The ClinicalTrials.gov registry entry for NCT00007644 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 731 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radical prostatectomy is the first listed.
NCT00007644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00007644 about?
NCT00007644 is a clinical study titled "Prostate Cancer Intervention Versus Observation Trial (PIVOT)". Radical prostatectomy provides potentially curative removal of the cancer. However, it subjects patients to the morbidity and mortality of the surgery and may be neither necessary nor effective. Expectant management does not offer potential cure. However, it provides palliative therapy for symptomat...
What is the current status of trial NCT00007644?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 731 participants. The study started on 1994-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00007644?
The interventions under investigation include: Radical prostatectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00007644?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.